Lena Ansmann1, Christoph Kowalski2, Holger Pfaff3, Rachel Wuerstlein4, Markus Antonius Wirtz5, Nicole Ernstmann6. 1. Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Faculty of Human Sciences and Faculty of Medicine, University of Cologne, Eupener Strasse 129, 50933 Cologne, Germany. Electronic address: lena.ansmann@uk-koeln.de. 2. Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Faculty of Human Sciences and Faculty of Medicine, University of Cologne, Eupener Strasse 129, 50933 Cologne, Germany. Electronic address: christoph.kowalski@uk-koeln.de. 3. Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Faculty of Human Sciences and Faculty of Medicine, University of Cologne, Eupener Strasse 129, 50933 Cologne, Germany. Electronic address: holger.pfaff@uk-koeln.de. 4. Department of Gynaecology and Obstetrics and Comprehensive Cancer Center, Ludwig Maximilian University, Marchioninistrasse 15, 81377 Munich, Germany. Electronic address: rachel.wuerstlein@med.uni-muenchen.de. 5. Institute of Psychology, University of Education Freiburg, Kunzenweg 21, 79117 Freiburg, Germany. Electronic address: markus.wirtz@ph-freiburg.de. 6. Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR), Faculty of Human Sciences and Faculty of Medicine, University of Cologne, Eupener Strasse 129, 50933 Cologne, Germany. Electronic address: nicole.ernstmann@uk-koeln.de.
Abstract
OBJECTIVES: To identify (1) how frequently patients are invited to take part and actually do take part in multidisciplinary tumor conferences (MTCs), (2) which patient characteristics affect whether they are invited to MTCs and whether they decide to participate, (3) the extent to which invitation and participation depend on the specific hospital. STUDY DESIGN: Survey data from 4146 newly-diagnosed breast cancer patients treated in 83 hospitals in North Rhine-Westphalia, Germany, were analyzed using multilevel modeling. RESULTS: 12% of the patients were offered participation in the MTC. More than half of these patients actually participated. Invitations to participate differed by patients' sociodemographic, disease, and treatment characteristics, whereas decisions to participate were largely independent of these characteristics. Invitation and participation are strongly dependent on the specific hospital. CONCLUSION: The practice of inviting cancer patients to MTCs requires further research, particularly on benefits and disadvantages for patients and ways of organizing MTCs.
OBJECTIVES: To identify (1) how frequently patients are invited to take part and actually do take part in multidisciplinary tumor conferences (MTCs), (2) which patient characteristics affect whether they are invited to MTCs and whether they decide to participate, (3) the extent to which invitation and participation depend on the specific hospital. STUDY DESIGN: Survey data from 4146 newly-diagnosed breast cancerpatients treated in 83 hospitals in North Rhine-Westphalia, Germany, were analyzed using multilevel modeling. RESULTS: 12% of the patients were offered participation in the MTC. More than half of these patients actually participated. Invitations to participate differed by patients' sociodemographic, disease, and treatment characteristics, whereas decisions to participate were largely independent of these characteristics. Invitation and participation are strongly dependent on the specific hospital. CONCLUSION: The practice of inviting cancerpatients to MTCs requires further research, particularly on benefits and disadvantages for patients and ways of organizing MTCs.
Authors: S Hollunder; U Herrlinger; M Zipfel; J Schmolders; V Janzen; T Thiesler; E Güresir; A Schröck; F Far; T Pietsch; D Pantelis; D Thomas; S Vornholt; N Ernstmann; T Manser; M Neumann; B Funke; I G H Schmidt-Wolf Journal: BMC Cancer Date: 2018-09-29 Impact factor: 4.430
Authors: Lena Ansmann; Alfred Schabmann; Sophie Elisabeth Gross; Anke Gross-Kunkel; Ute-Susann Albert; Igor Osipov Journal: Breast Care (Basel) Date: 2019-10-14 Impact factor: 2.860
Authors: Pola Hahlweg; Jana Hoffmann; Martin Härter; Dominick L Frosch; Glyn Elwyn; Isabelle Scholl Journal: PLoS One Date: 2015-10-06 Impact factor: 3.240